A novel drug re-positioning strategy for Parkinson's: Simultaneous, high content screening for translatable small molecules which are beneficial for mitochondrial and lysosomal dysfunction in primary fibroblasts from Parkinson's patients

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
Principal Investigator Last Name
Awardee Organization
Contact PI Country
Project Detail
FY Overall Cost
Funding Organization
Agency/Funding Organization
Funding Organization Country